diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Aged between 18 and 75; (2) Meeting the diagnostic criteria for diabetes after kidney transplantation; (3)8.0%=HbA1c=12.0%; (4) Those who agree to participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) combined with type 1 diabetes, type 2 diabetes or other causes and other special types of diabetes; (2) The estimated glomerular filtration rate was <45mL/min/1.73m2; (3) urogenital tract infection; (4) Patients with severe heart, lung, liver dysfunction and malignant tumors; (5) Unable to cooperate with or refuse to participate in the study due to serious mental illness; (6) Patients who are allergic to drugs used in this study; (7) Pregnant or lactating patients; (8) Severe complications of diabetes such as diabetic ketoacidosis or severe infections.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Plasma glucose;Glycosylated hemoglobin;Glutamic-pyruvic transaminase;creatinine;C-peptide;insulin;cholesterol;triglyceride;Low-density lipoprotein;Urinary trace albumin/creatinine;Stimulator of interferon genes;TANK-binding kinase 1;Interferon regulatory factor 3;interleukin 17;tumor necrosis factor a;Interferon-ß;CXCchemokineligand-10; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total type I collagen amino terminal extension peptide;osteocalcin;ß-collagen special sequence;25 hydroxyvitamin D;Meteorin-like protein; | — |
Countries
China
Contacts
900 Hospital of the Joint Logistics Team